A drug giant just got fined £37 million for ‘illegal behaviour’

Pharmaceutical giant GlaxoSmithKline (GSK) is getting a £37 million fine from the Competition and Markets Authority (CMA) over “illegal behaviour that is designed to stifle competition at the expense of customers — in this case, the NHS and, ultimately, taxpayers.”

The fine relates to a so-called “pay-for-delay” deals GSK reached with two generic drug makers between 2001 and 2004 to stop cheaper, non-branded versions of one of its “blockbuster” drugs being introduced to the market.

http://www.businessinsider.com/glaxosmithkline-fined-37-million-over-anti-depressant-drug-delay-deal-2016-2

Related

JOIN THE DISCUSSION